12:00 AM
 | 
Feb 27, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

LX4211 tablet: Completed Phase IIb enrollment

Lexicon disclosed in its 4Q11 earnings that it completed enrollment of 299 adult diabetics on metformin monotherapy in a double-blind, placebo-controlled, U.S. Phase IIb trial evaluating once-daily 75, 200 and...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >